Back
Fusion Pharmaceuticals Stock Price Chart
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Buy
80
FUSN
Fusion Pharmaceuticals
Last Price:
21.44
Seasonality Move:
-24.67%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FUSN is experiencing slight selling pressure.
Fusion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.42 | Buy |
| 20-day SMA: | 21.35 | Buy |
| 50-day SMA: | 17.56 | Buy |
| 200-day SMA: | 8.51 | Buy |
| 8-day EMA: | 21.41 | Buy |
| 20-day EMA: | 20.93 | Buy |
| 50-day EMA: | 18.22 | Buy |
| 200-day EMA: | 10.85 | Buy |
Fusion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 79.9 | Buy |
| Chaikin Money Flow: | -103449 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.28 - 21.42) | Buy |
| Bollinger Bands (100): | (7.7 - 19.12) | Buy |
Fusion Pharmaceuticals Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fusion Pharmaceuticals Stock
Is Fusion Pharmaceuticals Stock a Buy?
- Fusion Pharmaceuticals share price is 21.47 while FUSN 8-day simple moving average is 21.42, which is a Buy signal.
- The stock price of FUSN is 21.47 while Fusion Pharmaceuticals 20-day SMA is 21.35, which makes it a Buy.
- Fusion Pharmaceuticals 50-day simple moving average is 17.56 while FUSN share price is 21.47, making it a Buy technically.
- FUSN stock price is 21.47 and Fusion Pharmaceuticals 200-day simple moving average is 8.51, creating a Buy signal.
FUSN Technical Analysis vs Fundamental Analysis
Buy
80
Fusion Pharmaceuticals (FUSN)
is a Buy
Is Fusion Pharmaceuticals a Buy or a Sell?
-
Fusion Pharmaceuticals stock is rated a Buy
The current Fusion Pharmaceuticals [FUSN] share price is $21.47. The Score for FUSN is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
Fusion Pharmaceuticals Stock Info
Market Cap:
1.82B
Price in USD:
21.47
Share Volume:
352.67K
Fusion Pharmaceuticals 52-Week Range
52-Week High:
21.58
52-Week Low:
2.31
Buy
80
Fusion Pharmaceuticals (FUSN)
is a Buy
Fusion Pharmaceuticals Share Price Forecast
-
What is the Fusion Pharmaceuticals stock price today?
The Fusion Pharmaceuticals stock price is 21.47 USD today. -
Will FUSN stock go up or go down?
Fusion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Fusion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fusion Pharmaceuticals is not overvalued.
Is Fusion Pharmaceuticals Stock a Buy?
- Fusion Pharmaceuticals share price is 21.47 while FUSN 8-day exponential moving average is 21.41, which is a Buy signal.
- The stock price of FUSN is 21.47 while Fusion Pharmaceuticals 20-day EMA is 20.93, which makes it a Buy.
- Fusion Pharmaceuticals 50-day exponential moving average is 18.22 while FUSN share price is 21.47, making it a Buy technically.
- FUSN stock price is 21.47 and Fusion Pharmaceuticals 200-day simple moving average is 10.85, creating a Buy signal.
Fundamental Analysis of Fusion Pharmaceuticals
Is Fusion Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.18 per share.
Technical Analysis of Fusion Pharmaceuticals
Should I short Fusion Pharmaceuticals stock?
- FUSN Moving Average Covergence Divergence (MACD) indicator is 0.9, suggesting Fusion Pharmaceuticals is a Buy
- Fusion Pharmaceuticals Relative Strength Index (RSI) is 79.9, which suggest Fusion Pharmaceuticals is overbought
- The Bollinger Bands (25) for Fusion Pharmaceuticals is (21.28 - 21.42), which suggest Fusion Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Fusion Pharmaceuticals is (7.7 - 19.12), which suggest Fusion Pharmaceuticals is a Buy
* Fusion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.